pfizer, so there s some flexibility to do that. and i think that s where individual conversation needs to take place. but johnson & johnson, you need to get something. the efficacy rates were not high enough to feel like you can be protected months out. last question here, real quick. remember when johnson & johnson was first released, it was then subsequently paused for about ten days because this very rare side effect of blood clotting in individuals. is this currently a risk for people getting a second booster of johnson & johnson, yes, rare, but still a risk? it s rare. it was not seen in the boosted data population. i would say that s exactly the reason why i would say you should talk to your physician if you re a woman under the age of 50 and you are at higher risk and didn t experience anything with your j&j vaccine, it s worth having that conversation. so, i m glad you pointed that out. but no, they did not see any risks, so there s no increased risk, and it is incredibly r
Something
Conversation
Like-southlake
Pfizer
Flexibility
Johnson
Rates
Efficacy
People
Risk
Booster
Question